News from us and our partners

Tags

Topics

0 results

News
15 November, 2023
T-Therapeutics raises £48 million Series A for development of next generation TCR therapeutics to transform cancer treatment
News
15 November, 2023
Inari Medical closes $250M acquisition of LimFlow
News
15 November, 2023
Myricx Bio appoints Dr Chris Martin as board chairman
News
13 November, 2023
Sofinnova Partners enhances leadership in Medtech acceleration with key appointments
News
8 November, 2023
AAVantgarde appoints Dr. Peter K. Kaiser to the Board of Directors
News
7 November, 2023
Recor Medical and Otsuka Medical Devices announce first FDA-approved Renal Denervation System for the treatment of hypertension
News
3 November, 2023
Gender diversity in Venture Capital: “Visible and invisible barriers” slow progress
News
1 November, 2023
LimFlow announces agreement to be acquired by Inari Medical
News
1 November, 2023
Sitryx announces partner Lilly exercises option to SIT-011 for chronic autoimmune and inflammatory diseases
News
1 November, 2023
Inari Medical expands Its patient-focused mission with agreement to acquire LimFlow
News
30 October, 2023
AAVantgarde appoints Michael Heffernan as board chair
News
26 October, 2023
Betteromics raises $20 million in Series A financing, led by Sofinnova Partners and Triatomic Capital
News
26 October, 2023
L'école AI raises $3M seed from Sofinnova for machine teaching
News
26 October, 2023
Sofinnova Partners raises $200M Digital Medicine Fund
News
25 October, 2023
EnginZyme produces key mRNA vaccine ingredient using biocatalysis
News
25 October, 2023
Mediar Therapeutics announces clinical candidates for lead fibrosis programs, strategic collaborations and key leadership addition

T-Therapeutics raises £48 million Series A for development of next generation TCR therapeutics to transform cancer treatment

Inari Medical closes $250M acquisition of LimFlow

Myricx Bio appoints Dr Chris Martin as board chairman

Sofinnova Partners enhances leadership in Medtech acceleration with key appointments

AAVantgarde appoints Dr. Peter K. Kaiser to the Board of Directors

Recor Medical and Otsuka Medical Devices announce first FDA-approved Renal Denervation System for the treatment of hypertension

Gender diversity in Venture Capital: “Visible and invisible barriers” slow progress

LimFlow announces agreement to be acquired by Inari Medical

Sitryx announces partner Lilly exercises option to SIT-011 for chronic autoimmune and inflammatory diseases

Inari Medical expands Its patient-focused mission with agreement to acquire LimFlow

AAVantgarde appoints Michael Heffernan as board chair

Betteromics raises $20 million in Series A financing, led by Sofinnova Partners and Triatomic Capital

L'école AI raises $3M seed from Sofinnova for machine teaching

Sofinnova Partners raises $200M Digital Medicine Fund

EnginZyme produces key mRNA vaccine ingredient using biocatalysis

Mediar Therapeutics announces clinical candidates for lead fibrosis programs, strategic collaborations and key leadership addition